 Patients will receive androgen deprivation therapy ADT for a minimum of 1 year. After this, an intermittent hormone therapy approach will be taken, where ADT will not be restarted until the prostate specific antigen PSA reaches a minimum of 10-15 ngmL. Lupron 30 mg IM will be delivered every 4 months when on ADT. 